Article Abstract

The role of positron emission tomography in the diagnosis, staging and response assessment of non-small cell lung cancer

Authors: Sara Volpi, Jason M. Ali, Angela Tasker, Adam Peryt, Giuseppe Aresu, Aman S. Coonar


Lung cancer is a common disease and the leading cause of cancer-related mortality, with non-small cell lung cancer (NSCLC) accounting for the majority of cases. Following diagnosis of lung cancer, accurate staging is essential to guide clinical management and inform prognosis. Positron emission tomography (PET) in conjunction with computed tomography (CT)—as PET-CT has developed as an important tool in the multi-disciplinary management of lung cancer. This article will review the current evidence for the role of 18F-fluorodeoxyglucose (FDG) PET-CT in NSCLC diagnosis, staging, response assessment and follow up.